Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors at 4 institutions in 3 countries.
Telma de SousaMicroART-Antibiotic Resistance Team, Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal.ORCID 0000-0003-2326-6226
Carolina SabençaMicroART-Antibiotic Resistance Team, Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal.ORCID 0000-0002-7317-9123
Miguel RibeiroDepartment of Genetics and Biotechnology, University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal.
Mario Pino-HurtadoArea of Biochemistry and Molecular Biology, University of La Rioja, 26006 Logroño, Spain.ORCID 0000-0002-7475-7765
Carmen TorresArea of Biochemistry and Molecular Biology, University of La Rioja, 26006 Logroño, Spain.ORCID 0000-0003-3709-1690
Michel HébraudInstitut National de Recherche Pour l'Agriculture, l'Alimentation et l'Environnement (INRAE), Université Clermont Auvergne (UCA), UMR Microbiologie Environnement Digestif Santé (MEDiS), 63122 Saint-Genès-Champanelle, France.ORCID 0000-0003-0478-2575
Olimpia AlvesClinical Pathology Department, Hospital Centre of Trás-os-Montes and Alto Douro, 5000-508 Vila Real, Portugal.
Sara SousaClinical Pathology Department, Hospital Centre of Trás-os-Montes and Alto Douro, 5000-508 Vila Real, Portugal.ORCID 0000-0002-4555-8046
Eliana CostaClinical Pathology Department, Hospital Centre of Trás-os-Montes and Alto Douro, 5000-508 Vila Real, Portugal.
Gilberto IgrejasDepartment of Genetics and Biotechnology, University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal.ORCID 0000-0002-6365-0735
Patrícia PoetaMicroART-Antibiotic Resistance Team, Department of Veterinary Sciences, University of Trás-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal.ORCID 0000-0003-0925-689X
University of Trás-os-Montes and Alto Douro · PTUnidade Local de Saúde de Trás-os-Montes e Alto Douro · PTUniversidad de La Rioja · ESUniversité Clermont Auvergne · FR
Funding
Fundação para a Ciência e Tecnologia 2020.06967.BDFundação para a Ciência e Tecnologia DFA/BD/5332/2020Fundação para a Ciência e Tecnologia LA/P/0059/2020Fundação para a Ciência e Tecnologia UIDP/00772/2020
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Activity of Epsilon-poly-L-lysine against Multidrug-Resistant · full record | OpenQuestion